ArticleCureus2025
A Twice-Vanishing Lesion: Recurrent Stroke Mimic Reveals Cerebral Amyloid Angiopathy-Related Inflammation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral amyloid angiopathy-related inflammation (CAA-RI) is an uncommon inflammatory complication of CAA that can mimic stroke. Early recognition is critical, as the condition is often responsive to immunosuppressive therapy. We report a case of CAA-RI in a 63-year-old woman who presented twice with stroke-like symptoms, recurring seven years after the initial episode. Diagnosis is made on the basis of clinical suspicion and characteristic brain findings, which can be reversed with or without steroids. She first presented with confusion and vertigo. Magnetic resonance imaging (MRI) of the head with contrast showed increased T2 and fluid-attenuated inversion recovery (FLAIR) signal, along with hyperintensity on diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) in the right temporal lobe. She was started on dexamethasone 8 mg twice daily for a suspected tumor. On further review of the scans in the neuroradiology multidisciplinary team (MDT) meeting, the pattern of enhancement was not typical of a tumor, and the presence of punctate areas of hemosiderin deposition in both cerebral hemispheres on gradient-echo T2-weighted axial images was more suggestive of cerebral amyloid angiopathy/vasculopathy. Two months later, there was complete clinical and radiological resolution. After seven years, she presented with bilateral arm numbness and aphasia lasting for one hour. MRI showed features of a subacute infarct in the left middle cerebral artery territory, and the patient was treated with high-dose aspirin in view of the stroke. MRI performed for further characterization demonstrated subcortical T2 hyperintensity in the left temporoparietal region, with no underlying mass effect and no enhancement on post-gadolinium T1-weighted or FLAIR images. These findings were suggestive of cortical epileptic changes. The presence of subarachnoid FLAIR high signal was also noted, raising the possibility of meningitis or cerebritis. This was ruled out with a lumbar puncture (LP). Following a multidisciplinary team (MDT) discussion, she was diagnosed with cerebral amyloid-related seizure disorder. Repeat MRI at two months showed significant resolution of radiological changes, and MRI of the head after one year demonstrated complete radiological resolution. The diagnostic challenge faced by the treating physician, due to the clinical dilemma arising from varied presentations, can often lead to delayed or missed diagnosis. However, prompt recognition and treatment may result in full clinical and radiological recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.